Cara Therapeutics Inc. sell Sievi
Start price
24.08.21
/
0%
€16.20
Target price
24.08.22
-
Performance (%)
-24.81%
End price
25.08.21
€12.18
Summary
This prediction ended on 25.08.21 with a price of €12.18. The prediction for Cara Therapeutics Inc. closed with a convincing performance of -24.81%. This prediction was marked as speculative and is excluded from Sievi's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | 1.270% | 1.270% | -83.219% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to Sievi what are the pros and cons of Cara Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
